| CAS NO: | 151988-33-9 |
| 包装: | 500μg |
| 市场价: | 3371元 |
| Cas No. | 151988-33-9 |
| Canonical SMILES | CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C)([H])C)([H])CCSC)([H])C(C)C)([H])CO)([H])CCC(O)=O)([H])CC1=CC=CC=C1)([H])CC( |
| 分子式 | C141H210N32O44S |
| 分子量 | 3089.46 |
| 溶解度 | Soluble to 1 mg/ml in PBS |
| 储存条件 | Desiccate at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Ac2-26, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue[1]. References: |
m.cnreagent.com